EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

Featuring perspectives from Dr Jonathan Goldman and Dr Natasha B Leighl, including the following topics:

• Introduction (0:00)
• Current Management of Nonmetastatic and Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) — Prof Leighl (1:42)
• Promising Novel Agents in Clinical Development; EGFR Exon 20 Mutation-Positive NSCLC — Dr Goldman (37:25)

CME information and select publications